Chelsea Therapeutics International, Ltd. (NASDAQ:CHTP) Stock Quotes and News

Chelsea Therapeutics International, Ltd. (CHTP) 1.88 0.04

Price Open:	1.85	Day's Range:	0.00000 - 2.16000
Price Close:	1.84	52wk Range:	0.00000 - 5.74
Price Day Change:	0.04	Volume:	248,272
Price % Change:	2.17	Market Cap:	126.1M
Bid:	1.87000	PE Ratio:	0
Ask:	1.88000	EPS Diluted:	-0.30

Trade CHTP NOW!

The Latest On CHTP

Benzinga's Small Cap Movers for Wednesday February 20, 2013 2/20/13 10:37pm

Market Wrap for Wednesday February 20: Stocks Fall as Risks Re-Emerge; VIX up 19% 2/20/13 5:26pm

UPDATE: Wedbush Reiterates Outperform Rating, Raises PT on Chelsea Therapeutics International on Successful Appeal 2/20/13 3:16pm

Benzinga's Top Pre-Market Gainers 2/20/13 9:07am

FDA Issues Guidance for Chelsea Therapeutics' Northera, to Resubmit NDA in Late Q2, Says ST Benefit Enough to Support Okay 2/20/13 8:10am

Morning Market Losers 12/5/12 10:55am

Chelsea Therapeutics Announces Results from Northera Study 11/6/12 9:04am

Benzinga's Microcap Movers for Thursday October 25, 2012 10/25/12 8:55pm

Benzinga's Microcap Movers for Tuesday September 4, 2012 9/4/12 6:21pm

Branham Law, LLP Announces an Investigation of Chelsea Therapeutics International for Possible Securities Law Violations 8/24/12 4:25pm

Chelsea Therapeutics Falls 15% Amid Corp Reorganization 7/10/12 1:34pm

Benzinga's Microcap Movers for Friday July 6, 2012 7/6/12 4:54pm

Press Releases

Chelsea Therapeutics Reports First Quarter 2013 Financial Results 5/1/13 GlobeNewswire

Chelsea Therapeutics to Present at the 12th Annual Needham Healthcare Conference 4/24/13 GlobeNewswire

Chelsea Therapeutics Announces Presentation of Northera(TM) (droxidopa) Study 306 Data at the American Academy of Neurology Annual Meeting 3/19/13 GlobeNewswire

Chelsea Therapeutics to Present at the 25th Annual ROTH Conference 3/12/13 GlobeNewswire

Chelsea Therapeutics Reports Fourth Quarter and Full-Year 2012 Results 3/7/13 GlobeNewswire

Chelsea Therapeutics Receives FDA Guidance for a Northera(TM) (Droxidopa) NDA Resubmission With Study 306B 2/20/13 GlobeNewswire

Chelsea Therapeutics Announces Northera(TM) (Droxidopa) Study 306B Meets Primary Endpoint 12/4/12 GlobeNewswire

Get the latest CHTP stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Chelsea Therapeutics International, Ltd. stock price.

Partner Headlines

Columbia Wanger Chucks Chelsea, Despite FDA Progress 4/9/13

Encouraging News at Chelsea - Analyst Blog 2/21/13

Zacks #1 Rank Additions for Wednesday - Tale of the Tape 12/5/12

Zacks #1 Rank Additions for Friday - Tale of the Tape 11/30/12

Zacks #1 Rank Additions for Monday - Tale of the Tape 9/10/12

Zacks #1 Rank Additions for Monday - Tale of the Tape 8/27/12

Chelsea Therapeutics International Ltd. Reports Operating Results (10-Q) 8/7/12

Setback for Chelsea Therapeutics - Analyst Blog 7/6/12

BlackRock, HollyFrontier Among Stocks Down on High Volume Tuesday 5/22/12

Chelsea Therapeutics International Ltd. Reports Operating Results (10-Q) 5/1/12

Stocks Weaker on GDP Number, Jobless Claims 3/29/12